Audit 296689

FY End
2023-06-30
Total Expended
$9.68M
Findings
0
Programs
19
Organization: Aspire Indiana Health, Inc. (IN)
Year: 2023 Accepted: 2024-03-22
Auditor: Forvis LLP

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
L6AXPAJZ3HR4 Tim Crockett Auditee
3175870500 Nicholas Eichelman Auditor
No contacts on file

Notes to SEFA

Title: Note 1: Basis of Presentation Accounting Policies: Note 2: Summary of Significant Accounting Policies Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: Y Rate Explanation: Aspire Indiana, Inc. has elected to use the 10 percent de minimis cost rate allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the federal awards activity of Aspire Indiana Health, Inc. under programs of the federal government for the year ended June 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Aspire Indiana Health, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of Aspire Indiana Health, Inc.
Title: Note 3: Federal Awards Accounting Policies: Note 2: Summary of Significant Accounting Policies Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: Y Rate Explanation: Aspire Indiana, Inc. has elected to use the 10 percent de minimis cost rate allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards includes the federal awards activity of Aspire Indiana Health, Inc. for the year ended June 30, 2023 and does not include the expenditures of federal awards of the following subsidiaries of Aspire Indiana Housing, Inc.: Aspire Indiana Housing, Inc. Subsidiaries BehaviorCorp Properties, LLC $1,022,781 Apartment Living, Inc. $559,026 Group Living, Inc. $76,424 Group Living II, Inc. $353,112 InteCare Housing, Inc. $1,232,828 $3,244,171 Each of the entities noted above has received a separate financial statement audit performed as of and for the year ended June 30, 2023.
Title: Note 5: Federal Loan Programs Accounting Policies: Note 2: Summary of Significant Accounting Policies Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: Y Rate Explanation: Aspire Indiana, Inc. has elected to use the 10 percent de minimis cost rate allowed under the Uniform Guidance. Aspire Indiana Health, Inc. administered no federal loan programs for the year ended June 30, 2023